Aave Loans Face Liquidation Crunch as Collateral Takes Hours to Unwind

Liquidation Risks in Aave Loans

Aave's yield-bearing loans face a significant liquidation risk due to narrow buffers, with some loans requiring hours to cash out. This poses a challenge for borrowers seeking to grow their assets and for liquidators who need to recoup their investments quickly.

PT-AUSD Liquidation Route

The PT-AUSD loan has a narrow liquidation buffer, with a health factor of 1.01 and a sale quote of 1.18. This means that if a borrower becomes eligible for liquidation, a liquidator will need to sell the collateral at a price that is 18% higher than its current value. This can lead to significant losses for liquidators.

Arc syrupUSDC Liquidation Route

The Arc syrupUSDC loan also faces a liquidation risk, with a health factor of 1.02 and a sale quote of 1.01. This means that if a borrower becomes eligible for liquidation, a liquidator will need to sell the collateral at a price that is 1% higher than its current value. This can also lead to significant losses for liquidators.

Consequences for Borrowers and Liquidators

The liquidation risks in Aave loans can have significant consequences for both borrowers and liquidators. Borrowers may need to seek alternative assets to grow their assets, while liquidators may need to recoup their investments quickly to minimize losses.

Regulatory Environment

Aave's liquidation risks are also influenced by the regulatory environment. The US Securities and Exchange Commission (SEC) has issued guidance on the treatment of yield-bearing loans in DeFi, which may impact the way Aave operates and the risks it faces.